Kendall Capital Management
- SEC CIK
- 0001731372
- Latest filing
- Aug 12, 2026
UTHR holding history
United Therapeutics Corp in every 13F filed by Kendall Capital Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
UTHR overviewAll 13F holders of UTHRFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,881
- Value
- $3.19M
- % of portfolio
- 0.5%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,881 | $3.19M | 0.5% | −400−6.4% | Reduced | Holders |
| Q1 2026 | 6,281 | $3.72M | 0.8% | −278−4.2% | Reduced | Holders |
| Q4 2025 | 6,559 | $3.20M | 0.7% | −591−8.3% | Reduced | Holders |
| Q3 2025 | 7,150 | $3.00M | 0.7% | −30−0.4% | Reduced | Holders |
| Q2 2025 | 7,180 | $2.06M | 0.5% | −90−1.2% | Reduced | Holders |
| Q1 2025 | 7,270 | $2.24M | 0.7% | +475+7.0% | Added | Holders |
| Q4 2024 | 6,795 | $2.40M | 0.7% | +253+3.9% | Added | Holders |
| Q3 2024 | 6,542 | $2.34M | 0.7% | +340+5.5% | Added | Holders |
| Q2 2024 | 6,202 | $1.98M | 0.7% | +550+9.7% | Added | Holders |
| Q1 2024 | 5,652 | $1.30M | 0.4% | +1,440+34.2% | Added | Holders |
| Q4 2023 | 4,212 | $926.2K | 0.4% | +1,310+45.1% | Added | Holders |
| Q3 2023 | 2,902 | $655.0K | 0.3% | +1,557+115.8% | Added | Holders |
| Q2 2023 | 1,345 | $297.0K | 0.1% | +1,345 | New | Holders |